Preparation method of pyrimidine derivative 4, 6-dichloro-2-pyrimidine carboxylic acid methyl ester
The preparation of methyl 4,6-dichloro-2-pyrimidinecarboxylate, a pyrimidine derivative, via a two-step conversion reaction solves the problems of difficult methyl oxidation and low yield in existing technologies, and provides an efficient and low-cost preparation method.
Patent Information
- Application Number
- CN202411049524.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-01
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2044-08-01
AI Technical Summary
In existing methods for preparing methyl 4,6-dichloro-2-pyrimidinecarboxylate, the methyl group is difficult to oxidize, resulting in low yields.
Using 2-halo-4,6-dimethoxypyrimidine as a starting material, the target compound was prepared through a two-step conversion reaction. First, it reacted with carbon monoxide in the presence of a base and a catalyst to generate an intermediate. Then, it reacted with phenyl dichlorophosphate and concentrated hydrochloric acid.
It achieves a simple and low-cost preparation process with high yield, making it suitable for industrial production.
Smart Images

Figure CN118994030A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of organic synthesis, and in particular to a method for preparing pyrimidine derivative 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester. Background Art
[0002] Pyrimidine is an important class of nitrogen-containing heterocyclic compounds, which are widely present in the human body and organisms. For example, among the five most common nitrogen-containing alkaline components in nucleic acids, three contain pyrimidine structures, namely uracil, cytosine and thymine. A large number of studies have shown that pyrimidine compounds have insecticidal, bactericidal, herbicidal, antiviral and anticancer biological activities. For example, 5-fluorouracil, an anti-metabolite and anti-tumor drug widely used in clinical practice, has an inhibitory effect on many tumors; pyrrolo[2,3-d]pyrimidine compounds as immunosuppressants can be used to treat organ transplantation, type I diabetes and diabetic complications, cancer, asthma and other autoimmune diseases; ethidium bromide and dimethoate as fungicides can prevent and control powdery mildew of crops; quinazoline, pyrimidine and pyrimidinecarb as insecticides have insecticidal effects.
[0003] The pyrimidine derivative 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester is an important pharmaceutical and pesticide intermediate, which can be used in the fields of pesticides and medicines. The development of a synthetic method for the compound is of certain importance. In the prior art, the preparation method of 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester has not been reported, but the preparation of its reaction precursor 4,6-dichloro-2-pyrimidinecarboxylic acid has been reported in the literature. It is reported that the vinyl lithium reagent formed by tetravinyltin and n-butyllithium attacks 4,6-dichloropyrimidine to form 4,6-dichloro-2-vinylpyrimidine, and then the double bond is decomposed by ozonation to prepare 4,6-dichloropyrimidine-2-carboxaldehyde, which can be oxidized to prepare 4,6-dichloro-2-pyrimidinecarboxylic acid. This method uses expensive tetravinyltin reagents and has low atomic utilization. In addition, the ozonation decomposition in this method is not conducive to industrial production. In addition, there is also patent CN113767925 that uses 4,6-dichloro-2-methylpyrimidine as a raw material to directly oxidize the methyl group to prepare carboxylic acid, but the methyl group oxidation in this method is difficult and the yield is low.
[0004] In summary, the existing preparation method is difficult to methylate and has a low yield. To address the above problems, the existing method needs to be improved. Summary of the invention
[0005] The object of the present invention is to provide a method for preparing 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester, a pyrimidine derivative, so as to solve the problems of difficulty in methyl oxidation and low yield proposed in the above background technology.
[0006] To achieve the above object, the present invention provides the following technical solution: a method for preparing 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester, a pyrimidine derivative, using 2-halogenated-4,6-dimethoxypyrimidine as a raw material, and preparing 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester through two-step conversion, and the specific route is as follows:
[0007]
[0008] Furthermore, the following experimental steps are included:
[0009] (1) Compound 1 (2-halogenated-4,6-dimethoxypyrimidine) is dissolved in methanol, and then a base and a catalyst are added, and carbon monoxide is introduced, and the mixture is heated to 90-150° C. and stirred for reaction for 10-36 hours. After the reaction is completed, the reaction solution is post-treated to obtain Compound 2.
[0010] (2) Compound 2 is dissolved in an organic solvent 1, and then phenyl dichlorophosphate and concentrated hydrochloric acid are added, heated to 100-180° C., and stirred for reaction for 1-7 days. After the reaction is completed, the reaction solution is post-treated to obtain compound 3 (methyl 4,6-dichloro-2-pyrimidinecarboxylate).
[0011] Furthermore, in step (1), compound 1 is one of 2-bromo-4,6-dimethoxypyrimidine, 2-iodo-4,6-dimethoxypyrimidine, and 2-chloro-4,6-dimethoxypyrimidine.
[0012] Furthermore, in step (1), the base is one or more of triethylamine, potassium carbonate, sodium carbonate, sodium acetate, potassium acetate, and potassium phosphate.
[0013] Furthermore, in step (1), the catalyst is one or more of palladium acetate (Pd(OAc)2), bistriphenylphosphine palladium dichloride (Pd(PPh3)2Cl2), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (Pd(dppf)Cl2), and palladium dichloride (PdCl2).
[0014] Further, in step (1), the mass volume ratio of compound 1 to solvent methanol is 1:(5-40) g / mL;
[0015] The molar ratio of compound 1 to the base is 1:(1-5);
[0016] The molar ratio of compound 1 to the catalyst is 1:(0.01-0.05).
[0017] Furthermore, in step (1), the post-treatment is to cool the reaction solution, flush it into water, extract it with an organic solvent, combine the organic phases, wash the organic phases, dry them, and concentrate them to obtain a crude product, which is purified to obtain compound 2.
[0018] Furthermore, in step (1), the second organic solvent is one or more of ethyl acetate, butyl acetate, chloroform, toluene, dichloromethane, and dichloroethane.
[0019] Furthermore, in step (1), the purification method includes one or more of column chromatography, recrystallization, and distillation.
[0020] Furthermore, in step (2), the organic solvent 1 is one or more of toluene, dioxane, phenyl dichlorophosphate, N,N-dimethylformamide, N-methylpyrrolidone, and dimethyl sulfoxide.
[0021] Further, in step (2),
[0022] The mass volume ratio of compound 2 to solvent methanol is 1:(5-40) g / mL;
[0023] The mass volume ratio of compound 2 to concentrated hydrochloric acid (mass fraction 37%) is 1:(0.4-1.0) g / mL;
[0024] The molar ratio of compound 2 to phenyl dichlorophosphate is 1:1-10.
[0025] Furthermore, in step (2), the post-treatment is to cool the reaction solution, pour into ice water, stir for 1-5 hours, extract with an organic solvent three times, combine the organic phases, wash the organic phases with an alkaline aqueous solution, dry, and concentrate to obtain a crude product, which is purified to obtain the target compound 3.
[0026] Furthermore, in step (2), the organic solvent three is one or more of ethyl acetate, butyl acetate, chloroform, toluene, dichloromethane, and dichloroethane.
[0027] Further, in step (2), the alkaline aqueous solution is selected from one or more of sodium bicarbonate solution, sodium carbonate solution, potassium carbonate solution, sodium hydroxide solution, and potassium hydroxide solution;
[0028] Furthermore, in step (2), the purification method includes one or more of column chromatography, recrystallization, and distillation.
[0029] Compared with the prior art, the present invention has the following beneficial effects:
[0030] The present invention provides a preparation method of pyrimidine derivative 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester, using 2-halogenated-4,6-dimethoxypyrimidine as a starting material, and preparing 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester through two-step conversion. In the synthesis method, the starting material is cheap, simple and easy to obtain, and the intermediate is prepared by conventional carbonyl insertion reaction, which does not require low-temperature operation, and the reaction is simple and easy to operate; finally, the pyrimidine derivative 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester is prepared with short steps, simple operation, low cost, and relatively mild reaction conditions, and the product yield is high. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1 The hydrogen nuclear magnetic spectrum of 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester of the present invention is shown in FIG. DETAILED DESCRIPTION
[0032] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0033] A method for preparing 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester, a pyrimidine derivative, uses 2-halogenated-4,6-dimethoxypyrimidine as a raw material, and obtains 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester through two-step conversion. The specific route is as follows:
[0034]
[0035] Further, it comprises the following experimental steps:
[0036] (1) Compound 1 (2-halogenated-4,6-dimethoxypyrimidine) is dissolved in methanol, and then a base and a catalyst are added, and carbon monoxide is introduced, and the mixture is heated to 90-150° C. and stirred for reaction for 10-36 hours. After the reaction is completed, the reaction solution is post-treated to obtain Compound 2.
[0037] (2) Compound 2 is dissolved in an organic solvent 1, and then phenyl dichlorophosphate and concentrated hydrochloric acid are added, heated to 100-180°C, and stirred for reaction for 1-7 days. After the reaction is completed, the reaction solution is post-treated to obtain Compound 3.
[0038] The synthesis method provided by the present invention has the advantages of relatively mild reaction conditions, high yield, low cost, etc., and can be used to prepare compounds with specific structures.
[0039] In the following examples, unless otherwise specified, all reagents used are commercially available reagents, and all detection methods and detection means used are conventional detection methods and detection means in the art.
[0040] Example 1
[0041] A method for preparing 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester, the synthetic route is as follows:
[0042]
[0043] The specific steps are:
[0044] (1) Compound 1a (200.00 g, 1.15 molmol, 1.00 eq) was dissolved in methanol (2000 mL), and potassium acetate (337.29 g, 3.44 mol, 3.00 eq) and [1,1-bis(diphenylphosphino)ferrocene]palladium dichloride (25.15 g, 34.37 mmol, 0.03 eq) were added, carbon monoxide was introduced, the mixture was vented three times, and the mixture was heated to 130° C. and stirred for 12 hours. After the reaction was complete, the reaction solution was cooled, poured into water (4000 mL), and extracted with ethyl acetate three times (2000 mL*3). The organic phases were combined, and the organic phases were washed with water (4000 mL) and saturated brine (4000 mL) in turn, dried, and concentrated to obtain a crude product. The crude product was slurried with petroleum ether for 30 minutes to obtain compound 2 (weight 195 g, purity 98%, yield 84%).
[0045] (2) Phenyl dichlorophosphate (1.04 kg, 4.92 mol, 5.00 eq) was added to compound 2 (195.00 g, 983.96 mmol, 1.0 eq), and 37% concentrated hydrochloric acid (97.5 mL) was added, and the mixture was heated to reflux at 150° C. for 2 days. After the reaction was completed, the reaction solution was cooled, poured into ice water (2000 mL), stirred for 2 h, and extracted with ethyl acetate three times (1500 mL*3), the organic phases were combined, washed once with saturated sodium bicarbonate aqueous solution, dried, and concentrated to obtain a crude product, which was purified by column chromatography to obtain compound 3 (weight 171.00 g, purity 98%, yield 82%).
[0046] The H NMR spectrum of the obtained compound 3 is as follows Figure 1 The obtained characterization data are as follows:
[0047] 1 H NMR (400MHz, cdcl3) δ7.59 (s, 1H), 4.06 (s, 3H).
[0048] Example 2
[0049] A method for preparing 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester, the synthetic route is as follows:
[0050]
[0051] The specific steps are:
[0052] (1) Compound 1b (200.00 g, 913.08 mmol, 1.00 eq) was dissolved in methanol (2000 mL), potassium acetate (268.84 g, 2.74 mol, 3.00 eq), [1,1-bis(diphenylphosphino)ferrocene]palladium dichloride (20.04 g, 27.39 mmol, 0.03 eq) were added, carbon monoxide was introduced, the mixture was vented three times, heated to 130°C and stirred for 12 hours. After the reaction was complete, the reaction solution was cooled, poured into water (4000 mL), extracted with ethyl acetate three times (2000 mL*3), the organic phases were combined, washed with water (4000 mL) and saturated brine (4000 mL) once, dried, concentrated, and beaten with petroleum ether for 30 minutes to obtain compound 2 (weight 157.30 g, purity 98%, yield 85%).
[0053] (2) Phenyl dichlorophosphate (798.44 g, 3.78 mol, 5.00 eq) was added to compound 2 (150.00 g, 756.90 mmol, 1.0 eq), and 37% concentrated hydrochloric acid (75.0 mL) was added, and the mixture was heated to reflux at 150°C for 2 days. After the reaction was completed, the reaction solution was cooled, poured into ice water (2000 mL), stirred for 2 h, and extracted with ethyl acetate three times (1500 mL*3), the organic phases were combined, washed once with saturated sodium bicarbonate aqueous solution, dried, and concentrated to obtain a crude product, which was purified by column chromatography to obtain compound 3 (weight 131.20 g, purity 98%, yield 82%).
[0054] The H NMR spectrum of the obtained compound 3 is as follows Figure 1 The obtained characterization data are as follows:
[0055] 1 H NMR (400MHz, cdcl3) δ7.59 (s, 1H), 4.06 (s, 3H).
[0056] Although the present invention has been described in detail with reference to the aforementioned embodiments, it is still possible for those skilled in the art to modify the technical solutions described in the aforementioned embodiments, or to make equivalent substitutions for some of the technical features therein. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A method for preparing 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester, a pyrimidine derivative, characterized in that: Using 2-halogenated-4,6-dimethoxypyrimidine as raw material, 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester is prepared through two-step conversion. The specific route is as follows:
2. The method for preparing a pyrimidine derivative 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester according to claim 1, characterized in that: The following steps are involved: (1) Compound 1 is dissolved in methanol, and then a base and a catalyst are added, and carbon monoxide is charged, and the mixture is heated to 90-150° C. and stirred for reaction for 10-36 hours. After the reaction is completed, the reaction solution is post-treated to obtain Compound 2; (2) Compound 2 is dissolved in an organic solvent 1, and then phenyl dichlorophosphate and concentrated hydrochloric acid are added, heated to 100-180° C., and stirred for reaction for 1-7 days. After the reaction is completed, the reaction solution is post-treated to obtain Compound 3.
3. The method for preparing a pyrimidine derivative 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester according to claim 2, characterized in that: In step (1), compound 1 is one of 2-bromo-4,6-dimethoxypyrimidine, 2-iodo-4,6-dimethoxypyrimidine and 2-chloro-4,6-dimethoxypyrimidine.
4. The method for preparing a pyrimidine derivative 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester according to claim 2, characterized in that: In step (1), the base is one or more of triethylamine, potassium carbonate, sodium carbonate, sodium acetate, potassium acetate, and potassium phosphate.
5. The method for preparing a pyrimidine derivative 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester according to claim 2, characterized in that: In step (1), the catalyst is one or more of palladium acetate (Pd(OAc)2), bistriphenylphosphine palladium dichloride (Pd(PPh3)2Cl2), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (Pd(dppf)Cl2), and palladium dichloride (PdCl2).
6. The method for preparing a pyrimidine derivative 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester according to claim 2, characterized in that: In step (1), The mass volume ratio of compound 1 to solvent methanol is 1:(5-40) g / mL; The molar ratio of compound 1 to the base is 1:(1-5); The molar ratio of the compound to the catalyst is 1:(0.01-0.05).
7. The method for preparing a pyrimidine derivative 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester according to claim 2, characterized in that: In step (1), the post-treatment is to cool the reaction solution, flush it into water, extract it with an organic solvent, combine the organic phases, wash the organic phases, dry them, and concentrate them to obtain a crude product, which is purified to obtain compound 2.
8. The method for preparing a pyrimidine derivative 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester according to claim 7, characterized in that: In step (1), The second organic solvent is one or more of ethyl acetate, butyl acetate, chloroform, toluene, dichloromethane, and dichloroethane; The purification method includes one or more of column chromatography, recrystallization, and distillation.
9. The method for preparing a pyrimidine derivative 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester according to claim 2, characterized in that: In step (2), the organic solvent 1 is one or more of toluene, dioxane, phenyl dichlorophosphate, N,N-dimethylformamide, N-methylpyrrolidone, and dimethyl sulfoxide; The mass volume ratio of compound 2 to solvent methanol is 1:(5-40) g / mL; The mass volume ratio of compound 2 to concentrated hydrochloric acid (mass fraction 37%) is 1:(0.4-1.0) g / mL; The molar ratio of compound 2 to phenyl dichlorophosphate is 1:1-10; The post-treatment is to cool the reaction solution, pour into ice water, stir for 1-5 hours, extract with an organic solvent three times, combine the organic phases, wash the organic phases with an alkaline aqueous solution, dry, and concentrate to obtain a crude product, which is purified to obtain the target compound 3.
10. The method for preparing a pyrimidine derivative 4,6-dichloro-2-pyrimidinecarboxylic acid methyl ester according to claim 9, characterized in that: In step (2), The third organic solvent is one or more of ethyl acetate, butyl acetate, chloroform, toluene, dichloromethane and dichloroethane; The purification method includes one or more of column chromatography, recrystallization, and distillation.
Citation Information
Patent Citations
Process for preparing 2- pyrimidinecarboxylates
US5869667A
Compound usable in conjugation reaction and conjugate thereof
WO2024114528A1
Cited By
Synthesis method of compound 3-iodo-1H-indole-2-carboxylic acid
CN119613320A
Preparation method of methyl 2-pyrimidinecarboxylate
CN119775212A
